Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Behavioral Neurology & Neuropsychiatry
•
Primary Care
How long do you typically wait before starting anticoagulation after holding Leqembi/Kisunla in patients with cognitive impairment?
What is the typical washout period For these medications?
Related Questions
How do you implement antipsychotics in the management of agitation in Alzheimer’s patients?
How do you approach management of neurocognitive and memory deficits in post concussive syndrome?
How do you counsel elderly patients who demonstrate mild cognitive impairment but do not meet the criteria for a neurocognitive disorder?
When do you select cholinesterase inhibitors vs NMDA-antagonist medications in patients with moderate Alzheimer’s dementia?
Is a history of coronary artery disease and afib a contraindication to using donepezil?
How do you counsel patients who develop DVT or atrial fibrillation requiring anticoagulation when being treated with lecanemab or donanemab?
What is your approach to addressing dementia-related agitation for patients living at home with family?
What are the best practices for centers interested in providing anti-amyloid therapies for early Alzheimer's to ensure treatment delivery success?
When do you consider using stimulants in patients with cognitive impairments secondary to traumatic brain injury?
What nutritional supplements do you recommend for patients with ALS?